Laboratory Corporation of America Holdings (LH) Stake Lowered by Clinton Group Inc

Saturday, 13 Jan, 2018

Sei Investments Company who had been investing in Nvr Inc for a number of months, seems to be bullish on the $13.29 billion market cap company. The Company's dry bulk cargoes include grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The PE ratio shows how the company is performing in its financial terms compared to its competitors. Carroll Fin Associates holds 0.02% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH) for 1,155 shares. The institutional investor held 18,851 shares of the computer manufacturing company at the end of 2017Q3, valued at $2.91 million, down from 20,928 at the end of the previous reported quarter. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. The relative volume of the stock is 0.41. About 255,907 shares traded.

Laboratory Corp. of America (NYSE:LH) last released its quarterly earnings data on Wednesday, October 25th. It has underperformed by 6.19% the S&P500. The stock decreased 0.21% or $0.33 during the last trading session, reaching $154.99. It has underperformed by 40.63% the S&P500. Boston Prtnrs accumulated 4.62 million shares or 0.86% of the stock. Yost Capital Management L.L.C. owns 126,430 shares or 11.18% of their United States portfolio. Ohio-based Meeder Asset Inc has invested 0.16% in NVR, Inc. Ancora Advisors Limited Liability Corp, Us-based fund reported 4,238 shares.

Since January 1, 0001, it had 0 buys, and 1 insider sale for $6.78 million activity. Laboratory Corporation of America Holdings (NYSE:LH) has risen 10.51% since January 11, 2017 and is uptrending. The company reported $2.25 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $2.29 by $0.04. LH's profit will be $244.31 million for 17.73 P/E if the $2.40 EPS becomes a reality. After $2.07 actual EPS reported by Apple Inc. for the previous quarter, Wall Street now forecasts 81.16% EPS growth.

Laboratory Corp. of America earned a news sentiment score of 0.13 on Accern's scale. Its down 0.10, from 0.98 in 2017Q2. It is negative, as 41 investors sold LH shares while 239 reduced holdings. Parametrica Management Ltd has 0.12% invested in Laboratory Corporation of America Holdings (NYSE:LH). Nikko Asset Mngmt Americas holds 0.08% or 11,300 shares. Cleararc Capital Inc. raised its position in Laboratory Corporation of America Holdings by 0.8% in the second quarter. Colony Grp Limited Company invested in 0.03% or 3,349 shares. Westwood Hldgs holds 0% or 100 shares in its portfolio. Laboratory Corporation of America Holdings (NYSE:LH) has risen 10.51% since January 11, 2017 and is uptrending. ValuEngine raised shares of Laboratory Corp. of America from a hold rating to a buy rating in a research note on Thursday, November 30th. Fjarde Ap stated it has 25,439 shares. Dubuque Bancorporation invested in 2,879 shares. Whittier Tru Of Nevada Inc accumulated 85 shares or 0% of the stock. (NASDAQ:AAPL) for 3.47M shares. It also reduced its holding in Coca Cola European Partners by 734,754 shares in the quarter, leaving it with 3.16M shares, and cut its stake in Visa Inc (NYSE:V).

Since August 1, 2017, it had 0 buys, and 7 insider sales for $14.75 million activity. Shares for $459,739 were sold by Dodson Edward T on Tuesday, August 1. On Thursday, October 5 the insider Riccio Daniel J. sold $2.42M. EBERTS F SAMUEL III had sold 31,500 shares worth $4.89M on Friday, August 25. Following the transaction, the director now owns 3,501 shares in the company, valued at $537,473.52. During the same quarter last year, the firm earned $2.25 earnings per share. analysts predict that Laboratory Corp. of America will post 9.53 earnings per share for the current year. Jefferies maintained Laboratory Corporation of America Holdings (NYSE:LH) on Tuesday, September 12 with "Hold" rating. Credit Suisse downgraded Laboratory Corporation of America Holdings (NYSE:LH) on Wednesday, July 12 to "Hold" rating. Therefore 53% are positive. Laboratory Corp has $19000 highest and $117 lowest target. They issued a "buy" rating and a $180.00 price target for the company. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. The firm earned "Hold" rating on Friday, September 1 by Robert W. Baird. The company has market cap of $17.34 billion. The firm has "Neutral" rating given on Monday, February 6 by Robert W. Baird. Jefferies maintained it with "Hold" rating and $170.0 target in Thursday, October 19 report. The rating was maintained by Barclays Capital with "Overweight" on Tuesday, April 26. The company was downgraded on Tuesday, December 8 by Goldman Sachs. RBC Capital Markets maintained the shares of CF in report on Tuesday, October 17 with "Underperform" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.